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Semaphorin7A regulates neuroglial plasticity in the
adult hypothalamic median eminence
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Reproductive competence in mammals depends on the projection of gonadotropin-releasing
hormone (GnRH) neurons to the hypothalamic median eminence (ME) and the timely release
of GnRH into the hypothalamic–pituitary–gonadal axis. In adult rodents, GnRH neurons and
the specialized glial cells named tanycytes periodically undergo cytoskeletal plasticity.
However, the mechanisms that regulate this plasticity are still largely unknown. We
demonstrate that Semaphorin7A, expressed by tanycytes, plays a dual role, inducing the
retraction of GnRH terminals and promoting their ensheathment by tanycytic end feet via the
receptors PlexinC1 and Itgb1, respectively. Moreover, Semaphorin7A expression is regulated
during the oestrous cycle by the fluctuating levels of gonadal steroids. Genetic invalidation of
Semaphorin7A receptors in mice induces neuronal and glial rearrangements in the ME and
abolishes normal oestrous cyclicity and fertility. These results show a role for Semaphorin7A
signalling in mediating periodic neuroglial remodelling in the adult ME during the
ovarian cycle.
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R
eproduction in mammals is dependent on the function of
specific neurons that secrete gonadotropin-releasing
hormone (GnRH). These neurons project their axons to
the median eminence (ME) of the hypothalamus, which serves as
an interface between the neural and peripheral endocrine systems.
Here, GnRH is released into the pituitary portal blood vessels for
delivery to the anterior pituitary, to elicit the secretion of
luteinizing hormone (LH) and follicle-stimulating hormone1.
Alterations in the development of this system or in the secretion
of GnRH are associated with the reduction or failure of sexual
competence2.
It is increasingly recognized that in adult vertebrates, the
GnRH neuroendocrine system displays striking structural and
functional plasticity that is correlated with changes in the
animal’s physiological state3. Remarkably, both GnRH neurons
and the multiple neuronal networks involved in the control of
GnRH secretion are subject to direct modulation by peripheral
gonadal steroids4–7. During the ovarian cycle, under conditions of
low gonadotropin output, GnRH-secreting axon terminals are
distant from the pericapillary space of the ME, thus impairing the
access of the neurohormone to the pituitary portal circulation8.
There is now a growing body of evidence indicating that cell–cell
interactions involving non-neuronal cells such as vascular
endothelial cells, astrocytes and specialized ependymoglial cells
named tanycytes, which ensheathe the terminals of GnRH
neurons, might be of critical importance in the regulation of
GnRH secretion9–12. However, the molecular mechanisms
underlying this plasticity remain largely unknown.
Semaphorins are a family of soluble and membrane-bound
proteins first identified as potent chemorepulsive axon guidance
cues during development, where they play an essential role in
neural-network formation13,14. For example, we have recently
shown that Semaphorin7A (Sema7A) is essential for the
development of the GnRH neuronal system, and that loss of
Sema7A signalling during early development alters GnRH neuron
migration, resulting in significantly reduced numbers of these
neurons in the adult brain as well as in reduced gonadal size
and subfertility15,16. Intriguingly, these molecules are also
constitutively expressed in the postnatal brain and could thus
regulate neuronal plasticity and nervous system physiology in
adulthood14,17. We therefore asked whether Sema7A and its two
well-characterized receptors PlexinC1 and b1-integrin (Itgb1)
contribute to the periodic remodelling of the GnRH system in
adulthood.
Our results reveal a role for Sema7A signalling in mediating the
plasticity of GnRH neurons and tanycytes in the ME of the adult
hypothalamus via PlexinC1 and Itgb1, respectively. In particular,
our findings show that tanycytes, which insulate the pericapillary
space of pituitary portal vessels from GnRH nerve terminals,
express Sema7A, and that this expression is dynamically regulated
during the oestrous cycle by fluctuating gonadal steroid levels. We
also demonstrate that Sema7A induces rapid structural changes
in the ME, impairing the direct access of GnRH axons to the
portal vasculature, and that the inhibition of Rap1 is essential for
the Sema7A-mediated collapse of GnRH neuronal growth cones
in a PlexinC1-dependent manner. Moreover, we show that
tanycytes play an active role in mammalian reproduction via
Sema7A/Itgb1 signalling.
Results
Sema7A expression in the ME changes during the oestrous
cycle. As Sema7A is expressed postnatally in the ME18, where
GnRH terminals secrete their neurohormone, we investigated
whether this signalling molecule could play a role in the correct
functioning of the GnRH system during adulthood.
GnRH nerve terminals are located in close proximity to the
pericapillary space of pituitary portal blood vessels in the ME
during proestrus, in preparation for neurohormone release, but
they retract during diestrus19 as well as after gonadectomy20,
when GnRH secretion is low. To investigate whether this periodic
growth and retraction could be related to Sema7A levels, we used
western blotting to examine the expression of Sema7A in the ME
of female rats in diestrus II, in proestrus at the onset of the
preovulatory stage and during estrus. We found that the
expression of Sema7A was significantly increased on the day of
diestrus as compared with that of proestrus and estrus (Fig. 1a).
Quantification of Sema7A levels showed maximal levels on the
afternoon of diestrus II and thereafter progressively declining
expression during proestrus and estrus (diestrus versus proestrus
versus estrus, all at 1600 h).
To confirm these changes in Sema7A levels and confirm that
they are sex-steroid-dependent, we ovariectomized (OVX) cycling
adult female rats and subsequently treated these animals with
subcutaneous (s.c.) injections of sesame oil alone, or containing
17b-estradiol 3-benzoate (E2), progesterone (P4) or E2þ P4. As
shown in Fig. 1b, P4 induced a significant increase of Sema7A
expression in the ME of OVX rats as compared with the other
groups (Fig. 1b).
Sema7A expression varies in response to ovarian steroids. The
ME is one of eight circumventricular organs—regions sur-
rounding the cerebral ventricles—in the central nervous system,
in which the blood–brain barrier is modified to allow the release
of neurohormones produced by neuroendocrine cells from
terminals into the pituitary portal blood vessels for delivery to
the anterior pituitary21. The ME contains nerve terminals,
tanycytes, astrocytes and fenestrated endothelial cells. We next
determined the identity of the cell type(s) expressing Sema7A in
the ME and the factors regulating this expression.
We determined the expression pattern and cellular source of
Sema7A in the ME by fluorescent labelling experiments using
BSLI (Bandeiraea simplicifolia lectin I), which labels endothelial
cells and antibodies directed against Sema7A, vimentin and
GnRH, in the adult rat hypothalamus (Fig. 1c–f). Although no
Sema7A immunoreactivity was associated with endothelial cells
or GnRH terminals (Fig. 1c), we detected robust Sema7A
expression in tanycytes, identified by immunolabelling for
vimentin22 (Fig. 1d–f). No Sema7A protein was detected in the
ME of Sema7A / mutant mice (Supplementary Fig. 1a-d).
To determine whether the differences in Sema7A protein levels
in ME demonstrated above were due to modulation of tanycytes’
expression as a function of fluctuating gonadal steroids, we next
examined Sema7A transcript expression in tanycytes by stereo-
taxically injecting the Tat-cre fusion protein23 into the third
ventricle of tdTomatoloxP/þ reporter female mice (Fig. 1g). We
have recently shown that this method selectively achieves reporter
fluorescent protein expression in tanycytes, as opposed to
neurons, astrocytes or endothelial cells24. Cre recombination
occurred in virtually all vimentin-immunoreactive cells of the ME
(Fig. 1h).
We then isolated Tomato-positive cells from explants contain-
ing both the ME and the mediobasal hypothalamus by
fluorescence-activated cell sorting (FACS) and used quantitative
reverse transcriptase–PCR (RT–PCR) to verify the expression of
the tanycytic marker DARPP32 (ref. 25) (Fig. 1i). Sorted Tomato-
positive cells abundantly expressed DARPP32, which was barely
detectable in Tomato-negative cells24 (Fig. 1i). We therefore
isolated Tomato-positive and -negative cells from female mice in
diestrus and estrus, and performed quantitative RT–PCR
profiling for Sema7A (Fig. 1l).
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It has been reported previously that Sema7A is expressed by
hypothalamic neurons as well as in the ME18. Consistently,
Sema7A was expressed in both Tomato-positive and -negative
cells. Only tanycytic (Tomato-pos) Sema7A expression varies as a
function of the hormonal status of the animal (Fig. 1l), whereas in
Tomato-negative cells, Sema7A expression does not change
between diestrus and estrus.
We next determined whether tanycytes could respond directly
to changes in circulating gonadal steroid levels by verifying
the expression of oestrogen (ERa and ERb) and progesterone
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Figure 1 | Sema7A expression in ME tanycytes varies as a function of the oestrous cycle. (a) Western blotting for Sema7A in the ME during the oestrous
cycle. Bar graph illustrates the mean ratio (±s.e.m.) of the signal intensity obtained for Sema7A to that of total actin (n¼4 independent experiments per
oestrous cycle phase; 3- to 4-month-old females rats, Kruskal–Wallis test. *Po0.05, values are normalized to the Diestrus group). (b) Western blot
analysis for Sema7A and actin in the ME of control OVX rats and those treated with saline, 17b-estradiol 3-benzoate (OVXþ E2), progesterone
(OVXþ P4) and 17b-estradiol 3-benzoateþ progesterone (OVXþ E2þ P4). N¼4; 3- to 4-month-old females rats, Kruskal–Wallis test *Po0.05,
values are normalized to the OVX group. (c–f) Immunofluorescence for Sema7A, GnRH, BSLI and vimentin in coronal sections of the rat ME (n¼4 brains
for each experiment, 3- to 4-month-old females rats. Experiments were repeated five times). (c) Simultaneous triple-labelling experiments for Sema7A
(green), GnRH (blue) and the endothelial-cell marker BSLI (red). (d–f) Confocal images of double immunofluorescence for Sema7A (green) and vimentin
(red). Tanycytic processes (d, arrows) exhibit Sema7A immunoreactivity (c, arrows, f). 3V, third ventricle. (g) Tanycyte isolation by FACS and real-time
PCR analysis in Tomato-positive (pos; tanycytes) and -negative cells (neg) in tdTomatoloxP/þ mice infused i.c.v. with Tat-cre. (h) Tat-cre injection into the
third ventricle results in Cre-Lox recombination (red) exclusively in tanycytes (vimentin immunoreactive, green), whose cell bodies line the wall of the
third ventricle (asterisks). (i) Real-time PCR analysis of DARPP32 (n¼ 5 Tat-cre; tdTomatoloxP/þ ) mRNA in tanycytes isolated from Tat-cre;tdTomatoloxP/þ
mice, normalized to values in Tomato-negative cells. *Po0.01, Wilcoxon–Mann–Whitney test. (l) Real-time PCR analysis of Sema7A mRNA in tanycytes
isolated from Tat-cre;tdTomatoloxP/þ mice, normalized to values in Tomato-negative cells isolated from Tat-cre;tdTomatoloxP/þ mice at diestrus and estrus
(n¼4 Diestrus Tat-cre; tdTomatoloxP/þ versus n¼4 Estrus Tat-cre; tdTomatoloxP/þ ). *Po0.05, Kruskal–Wallis test. Values shown are means±s.e.m.
Scale bars, (c) 40 mm, (d–f) 80mm, (h) 100mm.
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receptors (PR-A/B), using RT–PCR on Tomato-positive and
-negative cells isolated as described above (Supplementary
Fig. 2a). Tomato-positive cells expressed ERa, ERb and
PR-A/B messenger RNAs, confirming that the cyclic variation
in Sema7A expression by tanycytes could indeed be directly
controlled by gonadal steroids.
Earlier studies have demonstrated that Sema7A expression is
regulated by transforming growth factor (TGF)-b1 in non-
neuronal tissues26. As TGF-b1 is expressed in the ME27,
including in tanycytes (Supplementary Fig. 2b), and because its
expression is known to fluctuate in the hypothalamus of adult
female rats during the oestrous cycle28, we next studied whether
progesterone regulates Sema7A expression in these cells by
modulating TGF-b1 expression. We generated primary cultures
of tanycytes from the rat ME (Fig. 2a–e) that we had previously
extensively characterized29,30, as FACS-sorted tanycytes do not
provide enough protein for western blotting.
Sema7A can act either as a membrane-bound molecule or as a
soluble factor following proteolytic cleavage13; we thus verified
that tanycytes express (Fig. 2d,e) and secrete Sema7A into the
culture medium (Fig. 2a).
To explore the role of P4, we used western blotting to confirm
the presence of progesterone receptors (PR-A and -B) in these
primary tanycyte cultures and analyse the expression TGF-b1 and
Sema7A proteins in total cell lysates (Fig. 2b). Coherently with
the in vivo data, primary tanycytes exposed to P4 (100 nM for 6 h)
expressed higher levels of TGF-b1 and Sema7A as compared with
untreated controls (Fig. 2c,d), an effect that was specific, as shown
by the lack of a response following the administration of P4
together with its antagonist, mifepristone (Fig. 2c). Moreover, the
effect of P4 on Sema7A expression was modulated by TGF-b1,
as it was prevented when tanycytes were treated with a TGF-b1-
neutralizing antibody in addition to progesterone (Fig. 2d).
Treatment of primary tanycyte cultures for 6 h with TGF-b1
promoted Sema7A protein expression in a dose-dependent
manner (with plateau activation at 10 ngml 1), thus confirming
that TGF-b1 is upstream Sema7A induction (Fig. 2e).
These findings show that increased Sema7A levels in diestrus
are controlled by progesterone, via the local cyclic release of TGF-
b1-regulating hypothalamic tanycytes in an autocrine/paracrine
manner.
Sema7A induces morphological plasticity in the ME. We have
previously shown that GnRH axon terminals, which are located
in close proximity to the pericapillary space surrounding pituitary
portal blood vessels in the ME during proestrus (the ME/GnRH
nerve terminals morphology in estrus is identical to the one seen
in diestrus), retract during the subsequent phases of the oestrous
cycle19,31. To assess whether this retraction is regulated by
Sema7A, we analysed hypothalamic explants containing the ME,
maintained ex vivo in artificial cerebrospinal fluid32. Explants
were treated with 1 mgml 1 Sema7A for 30min, fixed and
processed for electron microscopy using 15 nm gold-particle
labelling. As a function of the presence or absence of Sema7A
during proestrus, GnRH nerve terminals underwent a robust
transformation, with the distance between these terminals (green)
and the pericapillary space (pink) increasing significantly
in Sema7A-treated explants (Fig. 3a,b). A quantitative
morphometric analysis showed that although the total number
of GnRH nerve terminals at a distance of 10 mm from the
parenchymatous basal lamina (which delineates the pericapillary
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Figure 2 | Tanycytic Sema7A expression is progesterone and TGF-b1 dependent. (a) Western blot analysis of Sema7A-secreted protein in the
conditioned media (CM) of four representative tanycytic cultures 48 h after plating. (b) Representative western blotting showing the expression of
progesterone receptors, PR-A and PR-B, in primary tanycytes cell lysates (n¼4). Primary tanycytes were treated with progesterone (P) with or without its
antagonist Mifepristone (Mif), and TGF-b1 (c) and Sema7A (d) expression were evaluated by immunoblotting on total cell lysates (n¼ 3 independent
experiments for each treatment condition). (e) Representative immunoblot depicting a TGF-b1 dose–response experiment (6 h of treatment) on
Sema7A protein levels in primary tanycytes. Bar graphs illustrate the mean ratio of the signal intensity obtained for Sema7A to that for total actin
(n¼ 3 independent experiments per treatment; Kruskal–Wallis test *Po0.05; values are normalized to the control groups).
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space) did not vary significantly between treatments
(n¼ 4 animals per condition; 100–150 GnRH-immunoreactive
axon terminals were considered per explant; Wilcoxon–Mann–
Whitney test, P¼ 0.42), their distribution was markedly changed
(Fig. 3c). In fact, only a few GnRH-immunoreactive terminals
located at o1mm from the pericapillary space were detected in
ME explants, dissected at proestrus and exposed to Sema7A, as
compared with controls (Fig. 3a–c). The choice of 1-mm limit for
this quantitative analysis was made based on previous studies of
the spatial distribution of GnRH nerve terminals in the external
zone of the ME, which demonstrated that marked structural
changes only occur for the fraction of GnRH nerve terminals
located at o1 mm from the pericapillary space (not at 2, 3 or
10 mm distance from the basal lamina)33.
Bifunctional role of Sema7A in the hypothalamic ME. The axon
terminals of GnRH neurons are engulfed by tanycyte processes,
which periodically remodel under the influence of circulating
gonadal steroids to further restrict the proximity of GnRH
terminals to the pericapillary space of the ME12. We thus
evaluated whether Sema7A treatment might influence these
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Figure 3 | Sema7A induces morphological plasticity in the ME of the adult female brain. (a,b) Representative electron micrographs of GnRH-
immunoreactive axon terminals (immunogold) from hypothalamic explants containing the ME of female rat in proestrus, incubated in the absence
(a) or the presence (b) of Sema7A (1 mgml). GnRH axonal endings are highlighted in green, other neuroendocrine nerve terminals in yellow and the
pericapillary space (p.s.) in pink. (c) Quantitative analysis of the percentage of GnRH nerve terminals located o1mm from the pericapillary space in
the external zone of the ME, in explants from rats (3–4 months old mice) in proestrus treated or not with Sema7A (n¼4 animals per condition;
100–150 GnRH-immunoreactive axon terminals were considered per explant; Wilcoxon–Mann–Whitney test, *Po0.05). (d) Quantitative analysis of the
percentage of area occupied by tanycytes in the external zone of the ME ato2 mm from the pericapillary space, in explants from rats in proestrus treated or
not with Sema7A (*Po0.05; Wilcoxon–Mann–Whitney test; n¼ 5 in controls, n¼ 3 Sema7A-treated mice). (e) The schematic highlights the
morphological changes in GnRH terminals and tanycytic end-feet processes during the different phases of the ovulatory cycle. (f) Quantification of GnRH
secretion from ME explants dissected from adult female rats, during diestrus (n¼6) or proestrus (n¼6), stimulated or not for 4 h with Sema7A
(250ngml 1; n¼ 6). Conditioned medium was collected for each culture condition and processed by GnRH ELISA assay. GnRH concentrations are
represented as means±s.e.m. One-way ANOVA followed by Tukey’s post-hoc test, *Po0.01. Scale bars, (a,b) 2 mm.
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morphological rearrangements in tanycytes. Owing to their
anatomical organization (tanycyte processes are always closely
associated to the parenchymatous basal lamina), this second
analysis was performed by analysing the area occupied by
tanycytic end feet rather than their distance from the pericapillary
space. For this purpose, the analysis was performed within a
2-mm limit from the basal lamina of the ME, where the
morphological changes are more evident.
Following Sema7A stimulation, the area occupied by tanycytic
end feet (blue) rose from 63% to 88%, and only a few scattered
neuroendocrine nerve endings (yellow) were still present
(Fig. 3d). These data show that Sema7A induces the retraction
of GnRH nerve terminals and concomitantly promotes the
expansion of tanycytic processes, potentially making the perica-
pillary space inaccessible to these nerve terminals (Fig. 3e).
We then generated organotypic cultures of ME explants
dissected from adult female rats during diestrus II or proestrus,
and challenged them with Sema7A (250 ngml 1) for 2 h before
using enzyme-linked immunosorbent assay (ELISA) to measure
the amount of GnRH secreted into the medium (Fig. 3f). Under
control conditions, the concentration of GnRH detected in our
explant media remained low during diestrus II (Die) and
rose during proestrus (Pro), as expected. Following Sema7A
stimulation, the amount of GnRH secreted at proestrus was
reduced to diestrus levels (Fig. 3f).
Taken together, our data demonstrate that Sema7A treatment
of proestrus ME explants induces morphological changes of
GnRH and tanycytic processes, as well as modification of GnRH
secretion reminiscent of a diestrus state (Fig. 3e,f).
We next investigated the expression patterns of Sema7A
receptors, Itgb1 and PlexinC1, in the ME, using immuno-
fluorescence labelling and confocal microscopy (Supplementary
Fig. 3a–l). We confirmed that GnRH-positive axon terminals
located in the external zone of the ME co-expressed both Itgb1
(Supplementary Fig. 3a-d) and PlexinC1 (Supplementary
Fig. 3e–h). In addition, many Itgb1-immunoreactive fibres were
distributed throughout the internal zone and external zone of the
ME, where axons of other populations of neuroendocrine
neurons and tanycytic processes are located (Supplementary
Fig. 3a,i). Double-labelling experiments for PlexinC1 and
vimentin demonstrated that PlexinC1 is not expressed by ME
tanycytes, and confirmed that PlexinC1 immunoreactivity is
restricted to the external zone of the ME (Supplementary
Fig. 3i-l). The same antibodies were previously used to show
the differential expression of Itgb1 and PlexinC1 in GnRH
neurons during embryonic development15. Moreover, we further
tested the specificity of the PlexinC1 antibody on brain sections of
transgenic mice lacking PlexinC1 (Supplementary Fig. 1e–h).
Sema7A signalling in the retraction of GnRH neurites. As
biochemical studies of GnRH neurons are challenging because of
their limited number (800 in mice and 1,000–2,000 in primates)
and wide dispersal throughout the brain, we used GnV3 cells, one
of 11 clones of GnRH-expressing cells obtained by the conditional
immortalization of adult rat hypothalamic cell cultures34, to
perform subsequent functional and biochemical experiments.
Addition of doxycycline to the medium significantly stimulates
GnV3 cell proliferation, whereas removal of this compound
induces GnV3 cells to stop proliferating, differentiate and develop
many of the features of mature adult GnRH neurons, including
axon growth34,35. We first carried out western blot analyses to
verify the expression of Sema7A receptors in this model of GnRH
neurons (Supplementary Fig. 4a). Both PlexinC1 and Itgb1 were
detected in GnV3 cells, confirming our observations in the whole
brain and the pertinence of this model.
Sema7A stimulation of GnV3 cells activated ERK1/2 and
increased the level of cofilin phosphorylation, which is known to
inactivate cofilin by inhibiting its F-actin depolymerizing and
severing activity36,37 (Supplementary Fig. 4a), and to be a pivotal
signal transducer downstream of PlexinC1 (refs 38,39).
To confirm that the effects of Sema7A on GnRH nerve
processes were mediated by PlexinC1 and its downstream
effectors, we silenced PlexinC1 in GnV3 cells using a construct
coding for a PlexinC1 short hairpin RNA (shPlxnC1, Fig. 4a–c)
and analysed the effect of Sema7A on neurite growth (Fig. 4a,b).
Under basal conditions, the addition of Sema7A to the culture
medium induced a significant retraction (B70%) of neurites
(Fig. 4b,c), which was not detected following PlexinC1 knock-
down (Fig. 4a,b). Western blot experiments revealed that
Sema7A-induced phosphorylation of FAK, ERK1/2 and cofilin
is impaired in shPlxnC1-transfected cells as compared with
mock-transfected cells (Fig. 4c).
The intracellular region of the plexins contains a guanosine
triphosphatase (GTPase)–activating protein (GAP) domain for
Ras and its homologues40. Recently, Wang et al.41 showed that
semaphorin-induced dimerization stimulates plexin GAP activity,
thereby locally inactivating Rap1 and enabling neurite retraction
in rat cortical neurons. To determine whether Rap1 is involved in
the PlexinC1-dependent retraction of GnV3 neurites, we cultured
GnV3 cells that did or did not exogenously express the
constitutively active mutant construct Rap1-V12, which is
refractory to the effects of RapGAP42. Notably, Rap1-V12
overexpression prevented Sema7A-induced neurite retraction
(Fig. 4a,b). These data prompted us to directly test whether
Sema7A was responsible for Rap1 inactivation in GnV3 cells. To
this aim, we measured Rap1 activity by an affinity assay in which
Rap1-GTP was pulled down from lysates of GnV3 cells incubated
or not with Sema7A (250 ngml 1) for 1min. When compared
with untreated cells, Sema7A-stimulated cells displayed about
50% reduction of active Rap1-GTP (Supplementary Fig. 4b).
Sema7A-induced GnRH neurite retraction is physiologically
relevant. To evaluate the importance of Sema7A-PlexinC1 sig-
nalling in the control of adult reproductive function, adult female
rats with regular 4-day oestrous cycles were treated with Sema7A,
vehicle (saline) or Sema7A plus a recombinant decoy ectodomain
of PlexinC1, which acts as a ligand-trap sequestering Sema7A and
preventing its binding to endogenous receptors. The solutions
were infused into the ME via a cannula connected to a sub-
cutaneously implanted osmotic minipump for 7 days (Fig. 4d–f),
as described previously30. Within few days of infusion, Sema7A-
treated animals showed a disruption of regular oestrous cyclicity,
with 100% of days in the diestrus phase and a concomitant
reduction of days in proestrus as compared with vehicle-treated
animals (Fig. 4d,e,g). When Sema7A was neutralized by pre-
incubation with soluble PlexinC1, in equimolar ratio, before
infusion, rats maintained regular oestrous cyclicity (Fig. 4f,g).
Together with our ex vivo results, these data suggest that Sema7A
in the adult female brain is required for the neuroendocrine
control of the ovarian cycle.
As Sema7A is responsible for GnRH terminal retraction in a
PlexinC1-dependent manner, we next analysed whether the
permanent genetic invalidation of PlexinC1 would result in the
alteration of the GnRH innervation of the ME and/or in impaired
fertility. Indeed, GnRH innervation in the ME of PlexinC1 /
female mice was significantly more robust than in wild-type
littermates (Fig. 5a–d). We then examined the fertility of 3- to
6-month-old PlexinC1þ /þ , PlexinC1þ / and PlexinC1 /
mice. In contrast to the ovaries of control mice, which contained
large Graafian follicles and several corpora lutea, a histological
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Figure 4 | Sema7A induces the retraction of GnRH neurites through the PlexinC1 transduction pathway and Rap1 inactivation. (a) Representative
images of semaphorin-induced neurite retraction in GnV3 neurons transfected with an empty vector (mock), a construct encoding a PlexinC1 short hairpin
RNA (GnV3 shRNA PlexinC1) or a Rap1-V12 plasmid encoding a constitutively active form of Rap1. One day following Sema7A treatment (250 ngml 1),
cells were labelled for F-actin (red) to visualize cytoskeletal changes. (b) Quantitative analysis of neurite length in GnV3 cells under different treatment
conditions (n¼ 5 independent experiments, n¼ 303 mock-transfected control cells, n¼ 303 mock-transfected cells after Sema7A treatment, unpaired
Student’s t-test, ***Po0.0001; n¼ 267 shPlxnC1-treated cells, n¼ 235 shPlxnC1þ Sema7A-treated cells, unpaired Student’s t-test, P40.05; n¼ 131
Rap1-V12-transfected cells, n¼ 115 Rap1-V12-transfected cellsþ Sema7A, unpaired Student’s t-test, P40.05). (c) Immunoblotting for markers indicated
using transfected GnV3 cells. (d–f) Saline, Sema7A or Sema7Aþ PlexinC1 was infused (0.2mgml 1, 0.5ml h 1 for 7 days) by stereotaxic implantation of a
28-gauge infusion cannula connected to a subcutaneously implanted mini-osmotic pump in the ME of cycling female rats. Representative oestrous cycle
profiles showing the disruption of oestrous cyclicity by the infusion of Sema7A but not of PBS into the ME. Infusion was started on day 9 (downward arrow)
and ended 7 days later (upward arrow), when pump contents were exhausted. Die, Diestrus; Es, estrus; Pro, proestrus. (g) Quantitative analysis of
alterations in ovarian cyclicity (percentage of time in diestrus) caused by PBS, Sema7A or Sema7Aþ soluble PlexinC1 infusion into the rat ME (n¼6
animals per group, Kruskal–Wallis test, **Po0.005). Scale bar, (a) 10mm.
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inspection of the ovaries of adult PlexinC1þ / and PlexinC1 /
littermates revealed a significant reduction in the number of
corpora lutea and Graafian follicles, indicating a reduced number
of ovulations in mutant mice (Fig. 5e,f). The daily inspection of
vaginal cytology in these mice over a period of 2 weeks revealed
an absence of normal oestrous cyclicity, which was largely due to
increased duration of estrus in PlexinC1þ / and PlexinC1 /
animals as compared with wild-type females (Fig. 5g,h).
The observation that PlexinC1 mutant mice displayed altered
GnRH innervation in the ME and abnormal ovulation and
oestrous cyclicity suggested that the fertility of these mice could
be reduced. We therefore examined fertility in PlexinC1þ /þ ,
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Figure 5 | PlexinC1-deficient mice show abnormal GnRH innervation, ovulation, oestrous cyclicity and fertility. (a–d) Confocal photomicrographs
showing GnRH immunoreactivity in coronal sections of hypothalamic ME in wild-type (a,c; n¼ 7, females, 3–6 months old) and PlexinC1-null female mice
(b,d; n¼ 7, females, 3–6 months old). Arrowheads point to GnRH terminals and dotted lines define the basal lamina. Asterisks indicate the pituitary portal
vessel bed in the external zone of the ME. (e) Morphological analysis of ovaries from 3- to 6-month-old control (n¼ 5), PlexinC1þ / (n¼ 3) and
PlexinC1 / (n¼ 3) mice. Ovary sections (5mm thick) were stained with haematoxylin–eosin. In both heterozygous and homozygous PlexinC1 mice, the
ovaries displayed a greater number of atretic follicles (af) and a relative paucity of corpora lutea (cl) and Graafian follicles (gf) as compared with wild-type
littermates. (f) The numbers of corpora lutea and Graafian follicles were quantified in the ovaries of wild-type and mutant mice. Data are represented as
means±s.e.m. Kruskal–Wallis test, *Po0.05. Scale bar, 100mm (e). (g) Oestrous cyclicity in wild-type and PlexinC1 mutant mice. Vaginal cytology was
assessed for 15–17 days. (h) PlexinC1þ / and PlexinC1 / animals spent significantly more days in the oestrous phase (Es) and less in diestrus (Die) and
proestrus (Pro) as compared with control animals (PlexinC1þ /þ ) (n¼ 7 PlexinC1þ /þ , n¼ 9 PlexinC1þ / , n¼8 PlexinC1 / , Kruskal–Wallis test,
*Po0.05, **Po0.005, ***Po0.0005). (i) Schematic representation of the reproductive history of PlexinC1þ /þ (n¼ 7), PlexinC1þ / (n¼6) and
PlexinC1 / (n¼6) females. Black, grey and circled dots indicate litters produced by PlexinC1þ /þ , PlexinC1þ / and PlexinC1 / mice, respectively,
whereas X indicates an infertile female. Scale bars, (a,b) 100 mm, (c,d) 40mm.
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PlexinC1þ / and PlexinC1 / female mice using a continuous
mating protocol for 90 days. Control mice had an average of
3.6±0.2 litters during this period. The number of litters in
heterozygous female mice was 1.8±0.3, while homozygous
knockout female mice had an average of only 0.6±0.2 litters
during this period, confirming the reduction in the number of
ovulations (Fig. 5i; n¼ 6; one-way analysis of variance (ANOVA),
Po0.0001; Tukey’s all pairs comparison: PlexinC1þ /þ versus
PlexinC1þ / , Po0.0001; PlexinC1þ /þ versus PlexinC1 / ,
Po0.0001; PlexinC1þ / versus PlexinC1 / Po0.01).
Sema7A-Itgb1 signalling in tanycytic end-foot expansion. As
tanycytic end feet in the ME expand in response to Sema7A
(Fig. 3a,b,d), we investigated in vitro which receptors’ signal
transduction pathway is activated on Sema7A stimulation and
explored the possibility that Sema7A could act in an autocrine/
paracrine manner on these cells.
Our in vivo data demonstrate that vimentin-immunoreactive
tanycytes do not express PlexinC1 (Supplementary Fig. 3i–l).
To confirm the validity of our in vitro model, we first checked by
western blotting the expression of PlexinC1 in primary tanycytes
and in two positive controls, GnV3 cell line and ME tissues
(Fig. 6a). PlexinC1 was strongly expressed in both positive
controls but barely detectable or absent in tanycytes even when
twice as much protein extract was loaded as compared with GnV3
cells (Fig. 6a).
Western blot analyses were then carried out to determine the
expression of the other Sema7A receptor Itgb1 and the activation
of its signal transduction complexes following Sema7A treatment
(250 and 500 ngml 1). These experiments showed that tanycytes
expressed high levels of Itgb1, and that Sema7A induced the
phosphorylation of Itgb1 and its intracellular downstream
effector molecules FAK, ERK1/2 and AKT (Fig. 6b), but did
not affect the phosphorylation of cofilin, a known downstream
molecules of PlexinC1 (ref. 14).
To determine whether Sema7A could induce, also in vitro,
cytoskeletal remodelling and tanycyte processes expansion, we
inflicted a scratch wound on primary tanycytes and treated the
cells for 24 h with Sema7A (250 ngml 1). Exposure to Sema7A
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Figure 6 | Sema7A promotes tanycytic end-feet growth through the Itgb1 signalling pathway. (a) Representative western blotting showing the
expression of PlexinC1 and actin in primary tanycytes, in GnV3 cells and in median eminence (ME) lysates (positive control). Double amount of tanycytes
cell lysates as compared with GnV3 protein extracts were intentionally loaded (see actin bands) to ascertain the lack of PlexinC1 expression in these cells.
(b) Sema7A activates the Itgb1/MAPK pathway in primary tanycytes. Cells were treated with the indicated doses of recombinant Sema7A for 30min and
total cell lysates subjected to 3–8% SDS–PAGE and immunoblotting with the indicated antibodies. Experiments were done in triplicate with comparable
results. (c–j) Representative photomicrographs of a scratch-wound-healing assay performed on primary tanycytes treated or not for 24 h with recombinant
Sema7A (250ngml 1; n¼ 5 independent experiments). Continuous (e,f) and dotted (g,h) lines indicate the borders of the scratch at the initial recording
time. After 24 h of exposure to Sema7A, tanycytes invade a greater area of the scratch than in control cultures (e–h). (g–j) Immunolabelling of tanycytes
for paxillin (green) and F-actin (red) at 1 day in vitro (div) after treatment shows that Sema7A induces cytoskeletal remodelling in tanycytes, which quickly
develop end-feet-like structures (arrowheads, h) barely seen in control cells (arrowheads, g). Scale bars, (c–f) 30mm, (g–j) 20mm.
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improved the rearrangement of the cells, resulting in shorter
healing times than in untreated controls (Fig. 6c–f). The cultures
were fixed and labelled for F-actin (using phalloidin) and paxillin
(Fig. 6g–j). Sema7A stimulation induced extension of tanycytic
processes, which also displayed strong immunoreactivity for
paxillin (Fig. 6g,h; arrowheads), consistent with its involvement in
the dynamic adhesion required for cell protrusion.
These results show that Sema7A induces cytoskeletal remodel-
ling in tanycytes, in keeping with end-foot expansion observed
in vivo, probably through the activation of the Itgb1/FAK/
mitogen-activated protein kinase (MAPK) pathway.
Itgb1 function in normal GnRH secretion and ovulation. Given
that Sema7A signalling engaged Itgb1 activation in primary
tanycyte cultures (Fig. 6b), we next examined the involvement of
the Itgb1 signalling pathway in the cyclic morphological changes
of tanycytic end feet in the ME of adult mice, potentially con-
tributing to regulate the coupling between GnRH nerve terminals
and blood vessels. We used the injection of Tat-cre into the brain
of Itgb1loxP/loxP mice (Fig. 7a,b) to generate Tat-cre;Itgb1loxP/loxP
mice, in which Itgb1 (the b1-integrin gene) was selectively
knocked out in tanycytes. Hypothalamic MEs were acutely iso-
lated from Itgb1þ /þ and Itgb1loxP/loxP female mice 20 days after
Tat-cre stereotaxic injection, fixed and processed for electron
microscopy using 15 nm gold-particle labelling to visualize GnRH
terminals. Electron microscopic analyses of explants containing
the ME from preovulatory control mice in proestrus (Fig. 7c,d)
revealed the presence of several hypothalamic (yellow) and GnRH
(green) nerve terminals in close proximity to the pericapillary
space (pink; Fig. 7c). Following the conditional removal of Itgb1
in tanycytes (Fig. 7d), the area occupied by tanycytic end feet
(blue) at o2 mm from the pericapillary space was significantly
reduced by 20% as compared with controls (Fig. 7e), with a
corresponding increase in the space occupied by nerve terminals
(Fig. 7c,d).
Intriguingly, even though many GnRH nerve terminals were
found to be in close proximity to the parenchymatous basal
lamina in proestrus control explants (Tat-cre;Itgb1þ /þ ), no
direct contact between GnRH axons and the vascular wall was
seen in this group (Fig. 7c). However, in the Tat-cre;Itgb1loxP/loxP
group, we frequently observed GnRH terminals sprouting and
making direct contacts with the basal lamina of the ME (Fig. 7d,
arrows) in areas in which tanycyte processes engulfing GnRH
nerve terminals were much less conspicuous. Quantitative
analysis of the distance of GnRH nerve processes from the
pericapillary space confirmed that the percentage of GnRH-
immunoreactive terminals located in tight proximity with the
basal lamina (between 0 and 0.5 mm from the pericapillary space)
was significantly increased in Tat-cre;Itgb1loxP/loxP mice as
compared with control animals, whereas it did not change at a
distance between 0.5 and 1 mm (Fig. 7f).
These data show that the cell-specific removal of Itgb1
promotes tanycytic end-foot retraction in this region, making
the pericapillary space more accessible to GnRH nerve
terminals.
We then studied the physiological significance of Sema7A-
Itgb1 signalling in tanycytes by analysing the oestrous cycle in
these conditional knockout mice. We detected significant
alterations in oestrous cyclicity shortly after Tat-cre injection
(Fig. 7g). Similar to PlexinC1 knockout mice, Tat-cre;Itgb1loxP/loxP
animals spent more days in the oestrous phase and correspond-
ingly less in diestrus and proestrus than control animals (Tat-cre;
Itgb1þ /þ ) (Fig. 7g,i,j).
To examine the endocrine milieu contributing to abnormal
cycles in Tat-cre;Itgb1loxP/loxP mice, we measured LH as an index
of GnRH release in vivo. In adult Tat-cre;Itgb1loxP/loxP female
mice on estrus, serum LH levels were abnormally elevated
compared with the levels seen in control Tat-cre;Itgb1þ /þ
females (Fig. 7h). Pathologically elevated LH plasma concentra-
tions have been previously reported in a reproductive neuro-
endocrine model of polycystic ovary syndrome-like mice43.
These data suggest that removal of Itgb1 from tanycytes
reprogrammed the output of the hypothalamic–pituitary–gonadal
axis in adults, confirming the increased secretion of GnRH
into the pituitary portal blood vessels in the absence of tanycytic
end-foot expansion.
Discussion
Over the past two decades, it has become clear that GnRH
terminals of the ME undergo dynamic transformations as a
function of gonadectomy20 as well as of fluctuating physiological
conditions that influence the distance between GnRH terminals
and the basal lamina19. However, the molecular cues responsible
for these dynamic morphological changes have not been
elucidated so far.
Recent evidences suggest that the semaphorins continue to be
expressed in the postnatal brain and may have important
implications for neuronal plasticity and nervous system physiol-
ogy14. In recent years, there has been increasing interest in the
potential influence of semaphorins on the development and
homeostasis of hormone systems and, conversely, on how
circulating reproductive hormones could regulate semaphorins’
expression44.
Here we show that in the ME the tanycytic expression of
Sema7A varies as a function of the hormonal state of the animal
during the oestrous cycle, being maximal in the afternoon of
diestrus II. We propose that Sema7A released by hypothalamic
tanycytes cyclically induces GnRH neurons to retract their
terminals away from the pericapillary space through PlexinC1
signalling and concomitantly promotes tanycytic end-feet
expansion via Itgb1 activation, making the pericapillary space
inaccessible to GnRH nerve terminals. This mechanism regulates
neuropeptide release at key stages of the ovarian cycle, such as at
diestrus, when GnRH secretion into the portal circulation is low.
These results complement a recent study in which we
demonstrated the important role played by another semaphorin,
Sema3A, on the GnRH system at a different stage of the oestrous
cycle45. We indeed showed that the rise of oestrogen levels in
proestrus triggers the release of the 65-kDa isoform of Sema3A
(p65-Sema3A) by the endothelial cells of the ME, which in turn
promotes GnRH axonal elongation towards the vascular plexus to
facilitate GnRH release into the portal blood and thus modulate
the amplitude of the preovulatory LH surge45. Whereas in the
present study we suggest that in diestrus, when P4 secretion
reaches peak values (35 ngml 1)31,46 while oestrogen levels
are low (5 pgml 1)31,46, P4 stimulates Sema7A expression in
tanycytes and the Sema7A-mediated expansion of tanycytic end
feet, which ensheathe GnRH nerve terminals and thus prevent
free diffusion of the neurohormone into the percapillary space
(Figs 1b and 2d).
Altogether, these studies shed light on the molecular mechan-
isms responsible of the progression of the oestrous cycle in
rodents and suggest that this phenomenon relies, at least in part,
on the antagonistic effects of two ME semaphorins whose
expression is periodically influenced by circulating sex steroids,
estradiol (E2) and progesterone (P4), respectively.
It is tempting to speculate that, in mammalian species in which
P4 has been shown to terminate the GnRH/LH surge47,48, P4 may
arrest GnRH release by promoting the Sema7A-mediated
engulfment of GnRH nerve terminals by tanycytic end feet.
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Figure 7 | Itgb1 silencing in tanycytes of the ME disrupts neuroglial functional plasticity, oestrous cyclicity and LH levels. (a) Targeted Tat-cre delivery
into the third ventricle of Itgb1loxP/loxP and wild-type littermates Itgb1þ /þ . (b) Exon 3 of the Itgb1 gene is flanked by two LoxP sites and is excised after
cre recombination. Animals (3–6 months old) were killed 20 days after injection and ME was dissected and processed for electron microscopy.
(c,d) Representative electron micrographs of GnRH-immunoreactive axon terminals (immunogold, green), hypothalamic nerve terminals (yellow) and
tanycytic end feet (highlighted in blue) from proestrus Tat-cre;Itgb1þ /þ and Tat-cre;Itgb1loxP/loxP mouse hypothalamic explants containing the ME.
(d) Itgb1 removal in tanycytes induces tanycytic end-feet to retract from the pericapillary space (p.s., pink) and facilitates the sprouting of GnRH nerve
terminals towards the pericapillary space (arrows). (e) Quantitative analysis of the percentage of area occupied by tanycytes in the external zone of the
ME at o2 mm from the pericapillary space in explants from mice in proestrus in control and Itgb1-deleted mice (n¼ 6 Tat-cre;Itgb1þ /þ , n¼8
Tat-cre;Itgb1loxP/loxP, Wilcoxon–Mann–Whitney test, **Po0.005). (f) Quantitative analysis of the percentage of GnRH nerve terminals located between
0–0.5mm and 0.5–1mm from the pericapillary space in the external zone of the ME, in proestrus explants from control and Itgb1-deleted mice
(n¼6 Tat-cre;Itgb1þ /þ , n¼4 Tat-cre;Itgb1loxP/loxP, Wilcoxon–Mann–Whitney test, *Po0.05). (g) Oestrous cyclicity of Tat-cre;Itgb1loxP/loxP and
Tat-cre;Itgb1þ /þ animals was assessed for 16 days before Tat-cre injection and 20 days after injection in Tat-cre;Itgb1loxP/loxP (n¼ 12 Tat-cre;Itgb1þ /þ ,
n¼ 10 Tat-cre;Itgb1loxP/loxP, Wilcoxon–Mann–Whitney test, *Po0.01, **Po0.005). (h) Plasma LH levels in Tat-cre;Itgb1loxP/loxP and in Tat-cre;Itgb1þ /þ mice
(n¼8 Tat-cre;Itgb1þ /þ , n¼ 7 Tat-cre;Itgb1loxP/loxP, unpaired Student’s t-test, **Po0.005). Data are represented as means±s.e.m. (i,j) Representative
oestrous cycle profiles of Tat-cre;Itgb1þ /þ and Tat-cre;Itgb1loxP/loxP animals. Scale bars, (d) 1mm.
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Importantly, these experiments were never carried under non-
physiological ‘progesterone-only’ conditions, as ovariectomy does
not completely abolish circulating oestrogens. In fact, oestrogens
are also produced in smaller amounts by other tissues such as the
liver, adrenal glands and breasts (in rodents as well as in
humans)49,50. Moreover, we and others have shown that in OVX
rats, circulating oestrogens are still present at low levels
(8.1±1.6 pgml 1)51,52, reminiscent of the diestrus state
(between 5 and 15 pgml 1)31,46.
The physiological state of the female depends not on the
presence or absence, or even the levels of circulating ovarian
hormones per se, but on the ratio of progesterone to oestrogens53.
Thus, given the continued presence of small amounts of
extraovarian oestrogens even after ovariectomy, OVXþ P4
animals experience a high P4:E2 ratio, reminiscent of diestrus,
whereas in the OVXþ E2 or OVXþ E2þ P4 situations where
exogenous oestrogens are reintroduced, the P4:E2 ratio is much
lower, mimicking conditions during proestrus, when the
preovulatory LH surge occurs.
We also found a causal interaction between the expression
patterns of TGF-b1 and Sema7A, with the former being
upregulated in tanycytes in response to P4, and thereby
upregulating Sema7A in the same cells. These findings are in
agreement with previous studies showing that Sema7A expression
is stimulated by TGF-b1 in non-neuronal tissues26 and, together
with previous findings54, strongly suggest that tanycytes modulate
the secretory activity of GnRH neurons via juxtacrine interactions
involving TGF-b1 signalling and Sema7A-induced cytoskeletal
rearrangements in GnRH neurons and tanycytes. Consistently,
TGF-b1 mRNA expression in the ME FACS-isolated cells was
differentially expressed during the oestrous cycle, being
significantly higher in diestrus in both tanycytes (Tomato-
positive) and Tomato-negative cells (astrocytes and endothelial
cells). These data provide evidence that multiple cell types of the
ME express TGF-b1 and modulate its expression in response to
fluctuating levels of gonadal steroids, suggesting the existence of a
feed-forward mechanism. Accordingly, previous studies showed
that TGF-b1 is abundantly expressed in both glial cells and
capillaries in the rodent’s ME27.
Sema7A has been previously shown to bind PlexinC1 (ref. 55)
but no role was attributed to this interaction in neurons until
now. However, the high-affinity interaction of Sema7A and
PlexinC1 (ref. 55), together with their expression profile
pattern18, indicate the possibility of functional cooperation
between these proteins in neurons. In this work, we have
shown that GnRH neurons have the ability to directly respond to
fluctuating levels of tanycytic Sema7A through the activation of
PlexinC1, resulting in the physiologically crucial remodelling of
their processes.
We have previously shown that the expression pattern of the
two Sema7A receptors in GnRH neurons appears to be
spatiotemporally regulated: at early stages, migrating GnRH
neurons only express Itgb1, whereas they begin to express
PlexinC1 during subsequent developmental stages and in
anatomical areas at which these cells stop migrating15.
Moreover, we have demonstrated that the loss of Sema7A or
the conditional inactivation of Itgb1 in GnRH neurons had
impacts on the development of this system, resulting in the
significant reduction of the GnRH neuronal population in the
brain of adult mice, as well as reduced gonadal size and altered
fertility15,16. An analysis of PlexinC1 / embryos has not
revealed any difference in the migratory process of GnRH
neurons, indicating that Sema7A signals through Itgb1 to regulate
GnRH cell motility during development15. On the other hand, the
current work provides compelling evidence that PlexinC1 is
required to mediate the effects of Sema7A on mature (adult)
GnRH neurons.
Using GnRH cell lines, we have also demonstrated that
Sema7A rapidly induces actin cytoskeletal remodelling that leads
to the retraction of GnRH processes in a PlexinC1-dependent
manner. Whether similar phenomena actually occur in GnRH
nerve terminals in vivo is not known; however, our in vitro
experiments suggest that Sema7A activates the FAK–MAPK
pathway and inactivates cofilin via PlexinC1 signal transduction
pathway in GnRH neurons. Gene knockdown experiments
indicate that Sema7A-PlexinC1 binding triggers a signalling
cascade that leads to cofilin phosphorylation and cytoskeletal
remodelling, leading to axonal retraction. In support of these
findings, FAK–MAPK activation and the phosphorylation of
cofilin have previously been linked to Sema3A-induced growth-
cone collapse56,57. However, information regarding the signalling
pathways stimulated by PlexinC1 is fairly limited, even though in
other non-neuronal cell types, Sema7A binding to PlexinC1 can
induce the activation of LIM kinase II and inactivation of cofilin,
resulting in decreased cell adhesion and migration38,39.
The identification of the RasGAP domain in the plexins more
than a decade ago raised the critical question of which Ras family
member they acted on for signal transduction58,59. Recently,
Wang et al.41 have demonstrated that the purified cytoplasmic
region of the plexins uses a non-canonical catalytic mechanism to
act as a GAP for Rap, but not for R-Ras or M-Ras. In the same
work, they have also shown that among the plexins tested, the
highest GAP activity for Rap1 is displayed by the purified
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Figure 8 | Schematic of the Sema7A-action in the ME of the
hypothalamus. Schematic representation of the bifunctional mechanism of
action of Sema7A on tanycytes (yellow cells) and GnRH terminals (blue) as
a function of the oestrous phase. During diestrus, progesterone binds to its
specific receptors, PR-A/B in tanycytes. Tanycytes then overexpress
TGF-b1, which is responsible for the rise in Sema7A expression in
tanycytes. Sema7A induces the elongation of tanycytic end feet through
Itgb1 activation and retraction of GnRH nerve endings through the
engagement of PlexinC1 and inactivation of Rap1 in GnRH terminals.
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cytoplasmic region of PlexinC1. Consistent with these findings,
we have shown here that the Sema7A-induced neurite retraction
of GnRH neurons depends on the inactivation of Rap1. As the
F-actin-severing protein cofilin is a downstream target of the Rap
GTPases and the activation of this Rap–cofilin module is essential
for cytoskeletal changes crucial to B- and T-cell function60, we
hypothesize that Sema7A could promote neurite retraction in
GnRH neurons through a similar PlexinC1-mediated inactivation
of Rap1 and cofilin.
Using primary cultures of tanycytes, this study also highlights
how tanycytes remodel in response to Sema7A- Itgb1 signalling,
and the results obtained, notwithstanding their limitation
inherent to the use of an in vitro model system, further
substantiates the idea that the signalling pathways and effects of
individual guidance molecules vary as a function of cellular
context.
The functional consequences of the selective removal of Itgb1
in tanycytes of adult mice confirms that Itgb1 is required for the
expansion of tanycytic end feet and normal reproductive cyclicity.
Interestingly, this deletion leads to an alteration of the oestrous
cycle with a predominance of oestrous stages with elevated
circulating levels of LH. These mutant mice appear to
recapitulate, at least in part, the reproductive neuroendocrine
phenotype of the prenatal androgen-induced mouse model of
polycystic ovary syndrome43. Indeed, Sullivan and Moenter43
have previously shown that prenatal androgen-induced females
exhibit pathologically elevated levels of LH and a lengthening of
the oestrous cycles with an increased duration of estrus. Our data
thus suggest that alteration of the morphological plasticity of
tanycytes during the oestrous cycle could play important and
unexpected roles in the aetiology of some forms of hypothalamic
infertility. On the same line, recent findings showing that gonadal
steroids promote structural changes in the hypothalamus of
young women during the menstrual cycle61 and that mutation in
the SEMA7A gene can be found in patients with congenital
hypogonadotropic hypogonadism62 suggest that our results could
be of clinical relevance and may pave the way for the
development of new treatment strategies in the central loss of
reproductive competence in human syndromes and/or of new
contraceptive strategies.
All together, these data uncover a hitherto unknown
physiological role for tanycytes in the central control of fertility
and concur to validate the bifunctional nature of semaphorins,
here mediated by the differential engagement of PlexinC1 and
Itgb1 as alternative Sema7A receptors in distinct cell types
(Fig. 8). In addition, they enlighten the role of the semaphorin
signalling pathways in ependymoglial–neuronal plasticity, which
preserves homeostatic set points important for the survival of the
individual and the species.
Methods
Animals. All animals were housed under specific pathogen-free conditions in a
temperature-controlled room (21 C –22 C) with a 12 h light/dark cycle. Vaginal
smears were examined daily and only rats that exhibited at least two consecutive
4-day oestrous cycles were used for experiments. Diestrus I and II were defined by
the predominance of leukocytes in the vaginal lavage, the day of proestrus by the
predominance of nucleated round epithelial cells and the day of estrus by large
numbers of clustered cornified squamous epithelial cells.
Sprague–Dawley female rats (3–4 months old; Charles River, USA) were
provided ad libitum access to water and standard laboratory chow (Special Diet
Services, RM3, France, for mice; Purina lab chow, 5001, USA, for rats).
tdTomatoloxP/þ and Itgb1LoxP/LoxP mice (breeding pairs 3–6 months old), in which
exon three of Itgb1 is flanked by loxP sites, were purchased from the Jackson
Laboratories (Bar Harbor, ME). PlexinC1 and Sema7A mutant mice have been
previously characterized63. Animal use was in compliance with Inserm guidelines
for the care and use of laboratory animals and the European Communities Council
Directive of 24 November1986 (86/609/EEC) regarding mammalian research,
and approved by the Institutional Animal Care and Use Committee of Lille.
Drugs. Recombinant Sema7A (1835-S3) and soluble PlexinC1 (5375-PC) were
purchased from R&D Systems, MN, USA. TGFb1 was purchased from Millipore
(GF111). Progesterone for in vitro treatment was purchased from Sigma-Aldrich,
USA (P6149). 17b-estradiol 3-benzoate (E8515), 17b-estradiol (E8875),
progesterone (P0130) and sesame oil (S3547) were also purchased from
Sigma-Aldrich.
Ovariectomy and hormone treatments. Twenty cycling female rats (3- to 4-
month-old females rats) were bilaterally ovariectomized (OVX, day 0) under
anaesthesia by intraperitoneal injection of xylazine 10mg kg 1 (Rompun 2%,
Bayer) and ketamine 60mg kg 1 (Ketalar, Parke-Davis). Animals were divided in
4 groups: 16 animals were killed at 1400 h 17 days after ovariectomy without
receiving any treatment; 4 animals received a single s.c. injection of estradiol
benzoate (E2, 3 mg per rat) at 1000 h, 15 days after ovariectomy, and were killed at
1400 h 2 days later. Four animals received a single s.c. injection of progesterone
(P4, 30mg per rat) at 1000 h and were killed at 1400 h on day 17. Four rats were
injected with E2þP4 and three with saline only, and killed at 1400 h on day 17.
OVX, E2- and P-treated rats ME were used for western blot analysis to check the
expression of Sema7A and its receptors.
Infusion of Sema7A. Adult female rats with regular 4-day oestrous cycle were
treated with the Sema7A (n¼ 6), vehicle (n¼ 6, PBS) or Sema7Aþ soluble
PlexinC1 (n¼ 6, 5375-PC; R&D Systems). They were chronically infused into the
ME (bregma:  3.4mm, 10.25mm depth from the skull) through a stereotaxically
implanted infusion cannula (Plastics One, Roanoke, VA) connected to a sub-
cutaneously implanted mini-osmotic pump (model 1007D, flow rate 0.5 ml h 1,
capacity 100 ml, delivery period 7 days; Alzet, Palo Alto, CA). Each pump was
loaded with sterile PBS (Invitrogen) containing Sema7A (0.25 mg ml 1 final) or
Sema7A and PlexinC1 (0.25 mg ml 1). After connection to the infusion device and
overnight priming in 0.9% NaCl at 37 C, the assembly was implanted into cycling
190–200 g female rats. Oestrous cycle was monitored before and during surgery.
Subsequent to the infusion experiment, animals were killed, to assess the
implantation site of the cannula and check exhaustion of the infusion solution.
MEs were collected, snap frozen in dry ice and store at  80 C. To determine
whether infused molecules actually targeted the ME, animals were killed 7 days
after the initiation of the treatment, the brains were dissected and the sections of
20 mm thickness from the ME region of hypothalamus were cut and subjected to
immunohistochemistry for GnRH staining.
Tat-cre injection. Itgb1loxP/loxP female mice (3–6 months old, numbers of animals
used and corresponding genotypes are specified in the figure legends) and
tdTomatoloxP/þ female mice (3–6 months old, n¼ 5) were placed in a stereotactic
frame (Kopf Instruments, California) under anaesthesia (isoflurane) and a burr
hole was drilled 1.7mm posterior to the Bregma. A 10-ml Hamilton syringe was
slowly inserted into the third ventricle (5.6-mm deep relative to the dura) and 1.5 ml
of Tat-cre (2.1mgml 1) was injected using an infusion pump over 5min. The Tat-
cre fusion protein produced as detailed previously23.
Tanycyte cell culture. Tanycyte cell cultures were performed as previously
described29,30. Primary cultures of tanycytes were prepared using MEs dissected
from 10-day-old rats. After a growing period of 8–10 days in 75 cm culture flasks
containing DMEM-F-12 high-glucose medium supplemented with 10% calf serum
and 2mM L-glutamine, the astrocytes and tanycytes were isolated from
contaminant cells by overnight shaking at 250 r.p.m. and were plated either in
15 cm dishes (1–1.5 million cells per dish) for immunoblot analysis. For
immunohistochemistry, the cells were seeded in six-well plates on poly-L-ornithine
(100 mgml 1)- and laminin (2mgml 1)-coated coverslips. After reaching 90%
confluence, the medium was replaced with a serum-free, astrocyte- and tanycyte-
defined medium consisting of DMEM devoid of phenol red, supplemented with
2mM L-glutamine, 15mM HEPES, 5 mgml 1 insulin and 100 mM putrescine.
The cells were used 48 h later for experiments.
Immunohistochemistry. Animals were anaesthetized with 200mg kg 1 ketamine,
perfused transcardially with 5–10ml of saline, followed by 500ml of 4% paraf-
ormaldehyde in 0.1M phosphate buffer (PB), pH 7.4. Brains were removed and
immersed in the same fixative for 2 h at 4 C and stored in PB until slicing. Thirty-
five micrometres of free-floating coronal sections containing the ME region were
cut on a vibratome (VT1000S; Leica, Wetzlar, Germany) and collected in ice-cold
PB and blocked in PBS with 5% normal donkey serum (D9663; Sigma) and 0.3%
Triton X-100 (Sigma) for 1 h at RT before incubation with different primary
antibodies (mentioned in antibodies index below), and then washed extensively in
PBS and exposed to corresponding secondary antibodies (for details, see antibodies
index for immunohistofluorescence) tagged with Fluor 488-conjugated (1:500),
AlexaFluor 350 (1:500) and AlexaFluor 568 (1:500), for 1 h in 5% normal donkey
serum. After washes, slices were incubated for 2min with 0.02% Hoechst 33258
(H3569; Invitrogen) in PBS for fluorescent nuclear staining, and mounted on glass
slides and coverslipped with Permafluor medium (434990; Immunon, Pittsburgh,
PA). Control sections were incubated in the absence of a primary antibody and on
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brain sections of deficient mice (Sema7A and PlexinC1 knockout animals, 3- to
6-month-old female mice, n¼ 3). For these latter experiments, coronal sections
containing the ME were incubated for 24 h at 4 C in Sema7A (goat polyclonal;
1:400; AF1835; R&D Systems) or PlexinC1 (sheep polyclonal; 1:400; AF5375; R&D
Systems) primary antibodies diluted in 0.01M PBS, pH 7.4, 0.5% TritonX-100, and
1% normal serum, made in the same host species of the secondary antibody. For
the avidin-biotin-peroxidase method, sections were then incubated for 1 h at room
temperature (RT) in the appropriate secondary antibody (biotynilated horse anti-
goat IgG, or biotynilated rabbit anti-sheep IgG; Vector Laboratories, Burlingame,
CA) diluted 1:250 in 0.01M PBS, pH 7.4, followed by the avidin-biotin-peroxidase
complex (1:150; Vector Laboratories). To reveal immunoreactivity, we used 0.015%
3,30-diaminobenzidine (DAB) and 0.0024% H2O2 in 0.05M Tris-HCl, pH 7.6.
After adhesion on gelatin-coated glass slides, sections were dehydrated and
mounted in Sintex (Nuova Chimica, Cinisello Balsamo, Italy).
Sections were examined using an Axio Imager.Z1 ApoTome microscope (Carl
Zeiss, Germany) equipped with a motorized stage and an AxioCam MRm camera
(Zeiss). For confocal observation and analyses, an inverted laser scanning Axio
observer microscope (LSM 710, Zeiss) with an EC Plan NeoFluor  100/1.4
numerical aperture (NA) oil-immersion objective (Zeiss) was used (Imaging Core
Facility of IFR114 of the University of Lille 2, France).
Antibodies used for immunohistofluorescence experiments. The rabbit
polyclonal anti-GnRH (1:3,000) was a generous gift from Professor G. Tramu
(Centre Nationale de la Recherche Scientifique, URA 339, Universite´ Bordeaux I,
Talence, France).
Antibodies were against Sema7A (goat polyclonal; 1:400; AF1835; R&D
Systems), PlexinC1 (sheep polyclonal; 1:400; AF5375; R&D Systems), b1-Integrin
(rabbit polyclonal; 1:500, sc-8978; Santa Cruz), vimentin (chicken polyclonal,
1:2,000, AB5733, Millipore), progesterone receptors A/B (rabbit polyclonal, 3176S;
1:1,000, Sigma) and BSL-1 (endothelial cell marker, TRITC-labelled Bandeiraea
Simplicifolia Lectin BS-1 L5264, Sigma). A donkey anti-chick AlexaFluor
568-conjugated secondary antibody (1:500) was used for vimentin, the donkey
anti-rabbit AlexaFluor 488-conjugated secondary antibody (1:500) for Sema7A and
the donkey anti-mouse AlexaFluor 350-conjugated secondary antibody (1:500) for
GnRH detection. Phalloidin (1:100) used to stain actin cytoskeleton of fixed and
permeabilized cells was labelled with rhodamine and purchased from Invitrogen
(Eugene, OR).
Isolation of hypothalamic tanycytes using fluorescence activated cell sorting.
MEs from Tat-cre-injected tdTomatoloxP/þ female mice (3–6 months old, n¼ 5)
fed ad libitum were microdissected and enzymatically dissociated using a Papain
Dissociation System (Worthington, Lakewood, NJ), to obtain single-cell suspen-
sions. FACS analysis was performed using an EPICS ALTRA Cell Sorter Cytometer
device (Beckman Coulter, Inc.). The sorting decision was based on measurements
of tdTomato fluorescence (excitation: 488 nm; detection: bandpass 675±20 nm) by
comparing cell suspensions from tdTomato-positive and wild-type animals. For
each animal, 5,000–8,000 tdTomato-positive cells were sorted directly into 10 ml
extraction buffer: 0.1% Triton X-100 (Sigma-Aldrich) and 0.4U ml 1 RNase OUT
TM (Life Technologies).
Quantitative RT–PCR analyses. For gene expression analyses, mRNAs obtained
from FACS-sorted tanycytes were reverse transcribed using SuperScript III
Reverse Transcriptase (Life Technologies) and a linear preamplification step was
performed using the TaqMan PreAmp Master Mix Kit protocol (P/N 4366128,
Applied Biosystems). Real-time PCR was carried out on an Applied Biosystems
7900HT Fast Real-Time PCR System, using exon-boundary-specific TaqMan
Gene Expression Assays (Applied Biosystems) as follows: DARPP32
(Ppp1r1b: Mm00454892_m1), ERa (Esr1: Mm00433149_m1), ERb (Esr2:
Mm00599821_m1), PR-A/B (Pgr: Mm00435628_m1), TGF-b1 (Tgfb1:
Mm01178820_m1) and Sema7a (Sema7a: Mm01171202_m1). Control
housekeeping genes were r18S (18S: Hs99999901_s1) and ACTB (Actb:
Mm00607939_s1). Gene expression data were analysed using SDS 2.4.1 and
Data Assist 3.0.1 software (Applied Biosystems).
Immortalized GnRH cell line. GnV-3 cells are 1 of the 11 clones of GnRH-
expressing cells obtained by the conditional immortalization of adult rat hypo-
thalamic cell cultures34. GnV-3 cells express markers of well-differentiated neurons
and do not express markers of glial cells35. Cells were grown in proliferation
medium consisting of Neurobasal A medium with B27 supplement (20 ml ml 1,
Invitrogen-Gibco), PSN (1X, Invitrogen), Glutamax I (Invitrogen), Doxycycline
hydrochloride (0.5 mgml 1, Sigma), FBS (10 ml ml 1, Biological Industries) and
bFGF (5 ngml 1, Invitrogen). Doxycycline promotes the proliferation of these
conditional immortalized cells. To induce their differentiation, the culture medium
was replaced by differentiation medium (containing Neurobasal A, B27
supplement, PSN, and glutamax I and bFGF).
Short hairpin RNA for PlexinC1 and Rap1-V12 plasmids, employed for GnV3
transfections, were produced by Dr Tamagnone (Institute for Cancer Research at
Candiolo, University of Torino, Italy).
GnV3 morphological analysis. Changes in GnV3 cell morphology were evaluated
by staining the cells with Alexa 588-X phalloidin (Molecular Probes, Eugene, OR)
to visualize cytoskeletal actin. GnV3 cells were incubated overnight with or without
a recombinant human Semaphorin-7A/Fc chimera (100–250 ngml 1; 1835-S3,
R&D Systems). Quantification of GnRH fibre length was performed by an
experimentator, blind to culture treatments on digitized photomicrographs using
the NeuronJ plugin of ImageJ software (National Institute of Health, Bethesda,
USA).
Immunoblotting. Female rats (n¼ 4 independent experiments per oestrous cycle
phase; 3–4 months old) were decapitated at 1600 h on the day of diestrus II (Di16h)
or on proestrus or estrus at the same time (Pro16h). After rapid removal of the
brain, the meninges and optic chiasma were removed and the ME was dissected
under a binocular magnifying glass with Wecker’s scissors (Moria, France). After
dissection, each fragment was placed in a microcentrifuge tube, snap frozen in
liquid nitrogen and stored at  80 C.
Protein extracts of each ME sample were prepared in 100ml lysis buffer (pH 7.4,
25mM Tris, 50mM b-glycerophosphate, 1.5mM EGTA, 0.5mM EDTA, 1mM
sodium pyrophosphate, 1mM sodium orthovanadate, 10 mgml 1 leupeptin and
pepstatin, 10mgml 1 aprotinin, 100 mgml 1 phenylmethyl sulfonyl fluoride and
1% Triton X-100) by trituration of the fragments through 22- and 26-G needles in
succession. The tissue lysates were cleared by centrifugation at 12,000g for 15min
and protein content was determined using the Bradford method (BioRad, Hercules,
CA). We added 4 sample buffer (Invitrogen) and 10 reducing agent
(Invitrogen) to the samples and boiled for 5min before electrophoresis at 150V for
75min in precast 3%–8% SDS–polyacrylamide Tris-acetate gels according to the
protocol supplied with the NuPAGE system (Invitrogen, Carlsbald, CA). When
necessary, the samples were stored at –80 C until use.
For primary and immortalized cell extracts, samples were boiled for 5min after
thawing and electrophoresed for 75min at 150V for 75min in precast 3%–8%
SDS–polyacrylamide Tris-acetate gels according to the protocol supplied with the
NuPAGE system (Invitrogen). After size-fractionation, the proteins were
transferred onto Nitrocellulose membranes (0.2 mm pore-size membranes; LC2002;
Invitrogen) in the blot module of the NuPAGE system (Invitrogen) for 75min at
RT. Blots were blocked for 1 h in TBS with 0.05% Tween 20 (TBST) and 5%
non-fat milk at RT, incubated overnight at 4 C with their respective primary
antibodies and washed four times with TBST before being exposed to horseradish
peroxidase-conjugated secondary antibodies diluted in 5% non-fat milk-TBST for
1 h at RT. The immunoreactions were detected with enhanced chemiluminescence
(NEL101, PerkinElmer, Boston, MA).
The goat polyclonal anti-actin (sc-1616; 1:1,000), mouse monoclonal anti-P-
cofilin (sc271923; 1:500), rabbit anti-cofilin (sc33779; 1:500), rabbit anti-integrin
b1 (sc8978), mouse monoclonal anti-P-FAK (sc81493; 1:1,000) and mouse
monoclonal anti-FAK (sc56901; 1:500) antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). The rabbit monoclonal anti-phospho-Akt
(Ser473; 9275S; 1:1,000), rabbit monoclonal Akt (4691S; 1:1,000), rabbit polyclonal
anti-phospho-p44/42 MAPK (p-Erk1/2) (Thr202/Tyr204; 9101L; 1:1,000), rabbit
polyclonal anti-p44/42 MAPK (Erk1/2) (9102L; 1:1,000) and rabbit polyclonal
anti-progesterone receptor A/B (3176S; 1:1,000) antibodies were purchased from
Cell Signaling Technology (Beverly, MA, USA). Mouse anti-PlexinC1 (AF5375;
1:500) antibodies were purchased from R&D System (Beverly, MA, USA). Rabbit
anti-P-b1 integrin (AB5189; 1:500), rabbit anti-paxillin (AB2264; 1:500), rabbit
anti-Sema7A (ab23578; 1:500) and TGF-b1 (3176S; 1:500) antibodies were
purchased from Abcam Technology (Beverly, MA, USA). Secondary antibodies
used for western blotting detection (anti-mouse (1:8,000), anti-rabbit (1:10,000)
and anti-goat/sheep (1:10,000), all horseradish peroxidase-conjugated) were
purchased from Sigma (Saint-Quentin Fallavier, France).
Full images of western blottings are shown in Supplementary Figs 5–11.
Rap1 pull-down assay. Rap1-GTP pull-down was performed with the Active Rap1
pull-down detection kit (Thermo), according to the manufacturer’s protocol.
Briefly, GnV3 cells were grown for 3 days under differentiation condition34,35. Cells
were then stimulated with 250 ngml 1 Sema7A (R&D Systems) for 1min and
proteins were solubilized in a buffer provided with the kit (with protease
inhibitors). The same amount of total proteins was incubated with GST-tagged
Rap-binding domain of RalGDS (pre-loaded onto glutathione beads) to pull down
active GTP-bound Rap1. Rap1 levels in the different samples were then assessed by
western blotting analysis, by using Rap1 antibody (provided with the detection kit).
Assessment of ultrastructural changes in the ME. To determine ultrastructural
changes in GnRH nerve terminal plasticity, ex vivo experiments were carried out
according to previously described protocols19,31. Female rats weighting 250–300 g
(3–4 months old, n¼ 3–5 animals/experimental condition) were killed on diestrus
II or proestrus by decapitation. After rapid removal of the brain, hypothalamic
explants were microdissected without damaging the MEs. Explants were placed in
12-well plates and preincubated for 30min at 37 C in 1ml of Krebs–Ringer
bicarbonate buffer, pH 7.4, containing 4.5mgml 1 D-dextrose and 5 mM
tetrodotoxin, with or without recombinant human Semaphorin-7A/Fc chimera
(1 mgml 1; 1835-S3, R&D Systems), under an atmosphere of air containing 5%
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CO2. Explants were then processed for electron microscopy as described
previously19,31. Briefly, tissues were fixed by immersion in a solution of 2%
paraformaldehyde, 0.2% picric acid and 0.1% glutaraldehyde in 0.1M phosphate
buffer, pH 7.4, for 2 h at 4 C. Tissues were postfixed with 1% OsO4 in phosphate
buffer for 1 h at RT. After dehydration, tissues were embedded in Araldite.
Semithin sections (1–2 mm thick) were used to progressively approach and identify
the portion of the ME targeted for ultrastructural studies, that is, the area where the
pituitary stalk becomes distinct from the base of the hypothalamus but still remains
attached to it by the hypophyseal portal vasculature19. This area, which does not
extend beyond 20mm, contains high numbers of GnRH fibres. To detect GnRH
immunoreactivity, ultrathin sections (80–90 nm thick) collected on Parlodion
0.8%/isoamyl acetate-coated 100mesh grids (EMS, Fort Washington, PA) were
treated using an immunogold procedure described previously19. Briefly, after a
preliminary treatment with H2O2 (10%, 8min) and a blocking step in TBS (0.1M
Tris, pH 7.4, 0.15M NaCl) containing 1% normal goat serum and 1% bovine
albumin serum (10min at RT), the grids were floated on a drop of the following
reagents and washing solutions: (1) rabbit anti-GnRH (1:10,000) in bovine albumin
serum for 60 h at 4 C, (2) TBS to remove excess antibodies (three times for
10min), (3) colloidal gold (18 nm)-labelled goat anti-rabbit immunoglobulins
(Jackson ImmunoResearch) 1:20 in TBS for 90min at RT, (4) TBS (three times for
10min) and (5) distilled water (three times for 10min). The sections were then
counterstained with uranyl acetate and lead citrate before observation. The
specificity of the GnRH antisera used has been discussed previously19,31. Ultrathin
immunolabelled sections were examined with a Zeiss transmission electron
microscope 902 (Leo, Rueil-Malmaison, France) and images were acquired using a
Gatan Orius SC1000 CCD camera (Gatan France, Grandchamp, France). The
morphometric analysis was performed by an experimentator blind to the
hypothalamic explant treatment on digitalized images taken at an original
magnification of  12,000 from 10 to 15 ultrathin sections per animal, with a space
of 25 sections between them, to avoid taking the same GnRH nerve terminal into
consideration twice (the diameter of a GnRH nerve terminal rarely exceeds 2 mm).
All GnRH-immunoreactive nerve terminals located at o10mm from the
parenchymatous basal lamina (that is, the pial surface of the brain) were taken into
consideration, that is, more than 100 distinct axon terminals per animals (that is,
almost all GnRH nerve terminals abutting onto the pituitary portal blood vessels in
the aforementioned 20-mm-thick region of the ME). Immunolabelled terminals
confined to a distance of 10 mm or less from the basal lamina were imaged and the
distance from the nerve terminal and the pericapillary space recorded. The number
of immunoreactive GnRH terminals confined to a distance of o1 mm from the
basal lamina was then counted for each animal and multiplied by 100 to obtain the
percentage of GnRH terminals contacting the basal lamina in each treatment
condition. The area occupied by tanycytic end feet ato2 mm from the basal lamina
was also evaluated for each animal and under each treatment condition.
Similar electron microscopic analyses were performed in 3- to 6-month-old
proestrus Tat-cre;Itgb1þ /þ (n¼ 6) and Tat-cre;Itgb1loxP/loxP (n¼ 8) mice.
GnRH secretion determination. ME explants were dissected from female rats
(3–4 months old, n¼ 18) and processed as previously described32. Briefly, ME
explants were incubated in artificial cerebrospinal fluid with the following
composition (in mM): NaCl 117, KCl 4.7, NaH2PO4 1.2, NaHCO3 25, CaCl2 2.5,
MgCl2 1.2, glucose 10, bubbled with 95% O2–5% CO2 (pH 7.4, osmolarity
304mOsm). Medium was collected before and after explants were treated with or
without recombinant human Semaphorin-7A/Fc chimera (1 mgml 1; 1835-S3,
R&D Systems), followed by incubation at 37 C for 4 h at 300 r.p.m. Explants were
treated with KCl 0.05M at the end of the incubation period to confirm their
viability. Collected media were analysed for GnRH content following a GnRH
ELISA protocol (Phoenix Pharmaceuticals Inc., California, catalogue number FEK-
040-02).
Plasma LH assay. Plasma LH was measured using a Rodent LH ELISA kit
(Endocrine Technologies, Newark, CA) with a sensitivity of 0.03 ngml 1 and 7%
intra-assay and 10% inter-assay coefficients of variance.
Image analysis. For confocal observations and analyses, an inverted laser
scanning Axio observer microscope (LSM 710, Zeiss) with EC Plan NeoFluor
10 /0.3 NA, 20 /0.5 NA and 40 /1.3 NA (Zeiss) objectives were used
(Imaging Core Facility of IFR114 of the University of Lille 2, France). ImageJ
(National Institute of Health) and Photoshop CS5 (Adobe Systems, San Jose, CA)
were used to process, adjust and merge the photomontages.
Statistics. All analyses were performed using Prism 5 (GraphPad Software) and
assessed for normality (Shapiro-Wilk test) and variance, when appropriate. Sample
sizes were chosen according to the standard practice in the field. Data were
compared by a two-tailed unpaired Student’s t-test, one-way ANOVA for multiple
comparisons or by two-way repeated-measures ANOVA. A Tukey’s post-hoc test
was performed when appropriate. The significance level was set at Po0.05. For
comparison between two or multiple groups not having a normal distribution, the
non-parametric tests unpaired test (Wilcoxon–Mann–Whitney) and Kruskal–
Wallis, respectively, were used. A P-valueo0.05 was considered to indicate a
significant difference. Data groups are indicated as mean±s.e.m. The number of
biologically independent experiments, P-values and sex of the animals are indicated
in the figure legends.
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